Monday, 29 November 2010

Yet Another Johnson & Johnson Recall of Children's Medication

It’s the latest recall for a company that is already reeling under federal and state investigations for quality deficiencies. More Johnson & Johnson children's medications are being recalled due to “insufficiencies” in manufacturing.

The latest recall involves at least 800,000 bottles of children's Motrin and about 4 million packages of children's Benadryl allergy tablets. The recall specifically includes Children's Benadryl Allergy Fast Melt Tablet in cherry and grape flavors. Besides the US, these were distributed in Belize, Barbados, Saint Martin, Saint Thomas, Puerto Rico and Canada. Also involved in the recall are Junior Strength Motrin caplets distributed in the United States.

So far, the recall has not been linked to any reports of adverse events or injuries. According to Johnson & Johnson, there is no indication that the products do not meet quality standards, and consumers can continue to use these products.

Johnson & Johnson's latest recall comes during a year that has been plagued by massive recalls of children's medications related to musty smells and overdoses of active ingredients. The company has also been the subject of federal and state investigations into quality control inadequacies. J & J’s problems have been serious enough to warrant Congressional hearings.

At the center of the storm is Johnson & Johnson’s subsidiary McNeil Consumer Health, which manufactured the children's medications that were involved in the earlier recalls. Soon after those recalls, the company shut down a Fort Washington plant, which led to the loss of more than 300 jobs.

All these quality control inadequacies have meant not just increased scrutiny from California pharmaceutical liability lawyers, but also loss of confidence and trust from parents and doctors everywhere. Surveys have found that the company’s reputation has dropped by 27% among mothers, and 31% among pediatricians.

1 comment: